Sanofi (SNY) Cash from Operations (2019 - 2026)
Sanofi's Cash from Operations history spans 9 years, with the latest figure at 1970364929.08 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 10.5% to 1970364929.08 in Q1 2026 year-over-year; TTM through Mar 2026 was 23402913526.15, a 15.29% increase, with the full-year FY2025 number at 12513467783.01, up 28.95% from a year prior.
- Cash from Operations hit 1970364929.08 in Q1 2026 for Sanofi, down from 11237676090.9 in the prior quarter.
- Over the last five years, Cash from Operations for SNY hit a ceiling of 11967679607.6 in Q4 2023 and a floor of 495368285.1 in Q2 2024.
- Historically, Cash from Operations has averaged 5157177933.64 across 5 years, with a median of 3057316838.85 in 2022.
- Biggest five-year swings in Cash from Operations: plummeted 155.68% in 2024 and later soared 434.08% in 2025.
- Tracing SNY's Cash from Operations over 5 years: stood at 11195174339.4 in 2022, then grew by 6.9% to 11967679607.6 in 2023, then decreased by 12.22% to 10505361379.0 in 2024, then grew by 6.97% to 11237676090.9 in 2025, then crashed by 82.47% to 1970364929.08 in 2026.
- Business Quant data shows Cash from Operations for SNY at 1970364929.08 in Q1 2026, 11237676090.9 in Q4 2025, and 8539947442.32 in Q3 2025.